Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio Now
https://www.zacks.com/stock/news/2204955/reasons-to-retain-shockwave-medical-swav-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204955
Jan 03, 2024 - ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
0
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
https://www.zacks.com/stock/news/2204891/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2204891
Jan 03, 2024 - Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
0
Why Investors Need to Take Advantage of These 2 Oils and Energy Stocks Now
https://www.zacks.com/stock/news/2204905/why-investors-need-to-take-advantage-of-these-2-oils-and-energy-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2204905
Jan 03, 2024 - Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
0
If You Invested $1000 in Martin Marietta a Decade Ago, This is How Much It'd Be Worth Now
https://www.zacks.com/stock/news/2204877/if-you-invested-1000-in-martin-marietta-a-decade-ago-this-is-how-much-it-d-be-worth-now?cid=CS-ZC-FT-tale_of_the_tape|investing_$1000-2204877
Jan 03, 2024 - Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
0
If You Invested $1000 in DexCom a Decade Ago, This is How Much It'd Be Worth Now
https://www.zacks.com/stock/news/2204878/if-you-invested-1000-in-dexcom-a-decade-ago-this-is-how-much-it-d-be-worth-now?cid=CS-ZC-FT-tale_of_the_tape|investing_$1000-2204878
Jan 03, 2024 - Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
0
Reasons to Add Parker-Hannifin (PH) to Your Portfolio Now
https://www.zacks.com/stock/news/2204857/reasons-to-add-parker-hannifin-ph-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204857
Jan 03, 2024 - Parker-Hannifin (PH) is set to benefit from strength across its businesses, Win Strategy, acquired assets and shareholder-friendly policies.
0
Here's Why You Should Invest in Aquestive (AQST) Stock Now
https://www.zacks.com/stock/news/2204853/here-s-why-you-should-invest-in-aquestive-aqst-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204853
Jan 03, 2024 - Here, we discuss some reasons why buying Aquestive Therapeutics (AQST) stock now may turn out to be a prudent move.
0
Here's Why You Should Retain Medtronic (MDT) Stock for Now
https://www.zacks.com/stock/news/2204570/here-s-why-you-should-retain-medtronic-mdt-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204570
Jan 02, 2024 - Investors are optimistic about Medtronic's (MDT) expansion in global markets and stable solvency position.
0
The New York Times Just Sued Microsoft and OpenAI. Should You Buy the Stock Now?
https://www.fool.com/investing/2024/01/02/the-new-york-times-just-sued-microsoft-and-openai/?source=iedfolrf0000001
Jan 02, 2024 - There could be a a big payoff coming for the media organization.
0
Here's Why Prudent Investors are Retaining AON Shares Now
https://www.zacks.com/stock/news/2204539/here-s-why-prudent-investors-are-retaining-aon-shares-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204539
Jan 02, 2024 - We expect AON's Reinsurance Solutions and Health Solutions businesses to play significant roles in top-line growth.
0